GlobalData on MSN1d
Globus Medical strengthens SCS market position with $250m Nevro dealGlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...
Stock analysts at Roth Capital dropped their FY2024 earnings per share (EPS) estimates for shares of Globus Medical in a ...
The CEO of Globus Medical said the deal will enable the Audubon ... Nevro has about 1,100 employees, while Globus has more than 5,000 workers. Founded in 2006, Nevro has developed the patented ...
Globus Medical will acquire Nevro for $250 ... executive officers and certain employees and other persons may be deemed to be participants in soliciting proxies from its stockholders in connection ...
Globus Medical expects the Nevro acquisition to be accretive to its earnings in the second year of operation. Globus Medical expects to report full financial results for 2024 and provide its updated ...
Globus will buy all outstanding Nevro shares for $5.85 per share under the terms of the agreement, therefore reflecting a 27% ...
AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback